Lumasiran Sodium
Generic Name: lumasiran sodium
Dosage form: POWDER. Active ingredients: LUMASIRAN (1 g/g). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: LUMASIRAN (1 g/g). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Vorasidenib
vorasidenib
Isocitrate Dehydrogenase 1 Inhibitor [EPC]
11 DESCRIPTION VORANIGO tablets contain vorasidenib, an isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor. Vorasidenib is present as the hemicitric acid hemihydrate co-crystal. The chemical name of the co-crystal is 6-(6-chloropyridin-2-yl)- N 2 , N 4 -bis[(2 R )-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine, 2-hydroxypropane-1,2,3-tricarboxylic acid, hydrate (2:1:1).
Butal/apap/caff
butal/apap/caff
Barbiturate [EPC]
Butalbital, Acetaminophen, and Caffeine Tablets, USP are supplied in tablet form for oral administration. Each tablet contains the following active ingredients: Butalbital, USP . . . . . . . . . .50 mg Acetaminophen, USP . . . . .325 mg Caffeine, USP . . . . . . . . . . .40 mg Inactive Ingredients: microcrystalline cellulose, crospovidone, croscarmellose sodium, corn starch, stearic acid, colloidal silicon dioxide, magnesium stearate, and FD&C Blue No. 1.
Colibacillinum Cum Natrum Muriaticum
colibacillinum cum natrum muriaticum
INDICATIONS: May temporarily relieve diarrhea and nausea.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.